Marcello Allegretti

Dompé (Italy) — Italy

Medicine · Health Sciences

41h-index6.4kcitations201works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chemokine receptors and signaling(27), Immune cells in cancer(26), Neutrophil, Myeloperoxidase and Oxidative Mechanisms(25), Extracellular vesicles in disease(16), Corneal Surgery and Treatments(16)

Publications201 total

Feasibility Study of Decellularized Corneal Lenticule in a Porcine Model for Macular Hole Closure
Ophthalmology and Therapy·2026Open Access
Unraveling Endocannabinoid Signaling Pathways in Cisplatin‐Induced Ototoxicity
The FASEB Journal·2026Open Access
Feasibility study of decellularized corneal lenticule in a porcine model for macular hole closure
Figshare·2026Open Access
Feasibility study of decellularized corneal lenticule in a porcine model for macular hole closure
Figshare·2026Open Access
Ladarixin Potential over the Effects of IL-8 and of Serum from Patients with Abdominal Aortic Aneurysm on Human Aortic Cells
Cells·2025Open Access
Validation of the FACIT-Fatigue scale in patients with locally advanced or metastatic breast cancer
The Oncologist·2025· 2 citedOpen Access
Evaluation of in vitro and in vivo release of recombinant human nerve growth factor from bioengineered human stromal lenticule
Frontiers in Bioengineering and Biotechnology·2025Open Access
The dual non-competitive CXCR1/2 inhibitor ladarixin impairs neutrophil extravasation without altering intravascular adhesion
Haematologica·2025· 2 citedOpen Access
Human nerve growth factor delivery to the retina: Quantitative methodology and mathematical modeling in preclinical settings
PNAS Nexus·2025Open Access
Beyond inflammation: the multifaceted therapeutic potential of targeting the CXCL8-CXCR1/2 axis in type 1 diabetes
Frontiers in Immunology·2025· 1 citedOpen Access
191-OR: Targeting IL-8/CXCR1-CXCR2 to Unleash Regulatory B Cells in Type 1 Diabetes
Diabetes·2025
Reparixin as a Potential Antiepileptogenic Agent: Modulation of the CXCL1–CXCR1/2 Axis and Seizure Activity in a Kindling Rat Model of Temporal Lobe Epilepsy
International Journal of Molecular Sciences·2025· 1 citedOpen Access
REPARIXIN AS A POTENTIAL ANTI-EPILEPTOGENIC AGENT: MODULATION OF CXCL1-CXCR1/2 AXIS AND SEIZURE ACTIVITY IN KINDLING MODEL OF TEMPORAL LOBE EPILEPSY
Preprints.org·2025Open Access
TNFα-CXCR1/2 partners in crime in insulin resistance conditions
Cell Death Discovery·2024· 10 citedOpen Access
<i>Distinctive Alterations in the Emperipolesis between Neutrophils and Megakaryocytes from the Bone Marrow of Gata1low Mice Documented By Time-Lapse Observations</i>
Blood·2024
Intranasal administration of recombinant human BDNF as a potential therapy for some primary headaches
The Journal of Headache and Pain·2024· 2 citedOpen Access
Supplementary Figure S6 from Tumor-Secreted Extracellular Vesicles Counteract Therapy Response by Triggering Inflammatory Mesenchymal Stem Cell Development
2024Open Access
Supplementary Figure S2 from Tumor-Secreted Extracellular Vesicles Counteract Therapy Response by Triggering Inflammatory Mesenchymal Stem Cell Development
2024Open Access
Supplementary Table S1 from Tumor-Secreted Extracellular Vesicles Counteract Therapy Response by Triggering Inflammatory Mesenchymal Stem Cell Development
2024Open Access
Supplementary Figure S7 from Tumor-Secreted Extracellular Vesicles Counteract Therapy Response by Triggering Inflammatory Mesenchymal Stem Cell Development
2024Open Access
page 1 of 11Next →

Frequent Co-authors

Laura Brandolini(14), Riccardo Bertini(13), Maria Candida Cesta(11), Cinzia Bizzarri(9), Flavio Mantelli(8), Mauro Martins Teixeira(7), Andrea Aramini(7), Maria De Pizzol(6), Paolo Rama(6), Andrea R. Beccari(6), Annamaria Cimini(6), Vanessa Castelli(6), Alessio Moriconi(5), Massimo Locati(5), Emanuela Galliera(5), Alessandro Lambìase(5), Michele d’Angelo(5), Elisabetta Benedetti(5), Roberto Anacardio(4), Francesco Colotta(4)